Subject
Molecular Medicine is a peer-reviewed open access medical journal published by The Feinstein Institute for Medical Research. It was established in 1994 by the Picower Institute for Medical Research, which had been established in 1991 by Anthony Cerami with funding from Jeffry Picower which eventually was absorbed into Feinstein.It is published in paper format six times annually. Manuscripts are posted online when they are accepted for publication. The journal covers research on the molecular pathogenesis of disease and translation of this knowledge into specific molecular tools for diagnosis, treatment, and prevention. It offers a biweekly podcast "Mollie Medcast", launched in 2007, which includes brief summaries of recent articles. In 2013 Feinstein began giving an annual award named after Cerami through the journal; the winner receives $20,000 and the offer to publish an autobiographical piece about their research and what drives it in the journal.As of 2014, the editor-in-chief is Betty Diamond. Molecular Medicine is indexed by PubMed and the Web of Science. According to the Journal Citation Reports, its 2013 impact factor is 4.824. Source: Wikipedia (en)
Editions published in Molecular Medicine 200
-
A Journey in Science: "Not Lost in Translation"
-
Pigmy MicroRNA: surveillance cops in Therapies kingdom
-
Emetine Di-HCl attenuates Type 1 diabetes mellitus in mice
-
Mutations in the Na(+)/citrate cotransporter NaCT (SLC13A5) in pediatric patients with epilepsy and developmental delay
-
Sex- and disease-specific inflammasome signatures in circulating blood leukocytes of patients with abdominal aortic aneurysm
-
Cadherin 13: human cis-regulation and selectively-altered addiction phenotypes and cerebral cortical dopamine in knockout mice
-
Cholinergic activity as a new target in diseases of the heart
-
Extracellular high-mobility group box 1 protein (HMGB1) as a mediator of persistent pain
-
Fibrocytes at 20 Years
-
Cysteine Oxidation Targets Peroxiredoxins 1 and 2 for Exosomal Release through a Novel Mechanism of Redox-Dependent Secretion
-
Aspirin's Active Metabolite Salicylic Acid Targets High Mobility Group Box 1 to Modulate Inflammatory Responses
-
Signatures of miR-181a on renal transcriptome and blood pressure
-
Once Upon a Time: The Adaptive Immune Response in Atherosclerosis--a Fairy Tale No More
-
Humanin Derivatives Inhibit Necrotic Cell Death in Neurons.
-
The role of HMGB1 in the pathogenesis of inflammatory and autoimmune diseases
-
Statins: definitive translational research
-
Molecular mechanisms of pulmonary arterial remodeling
-
Cell death and DAMPs in acute pancreatitis
-
Hypoxia-inducible aryl hydrocarbon receptor nuclear translocator (ARNT) (HIF-1β): is it a rare exception?
-
Advances in sickle cell therapies in the hydroxyurea era
-
Ken Warren and the Rockefeller Foundation's great neglected diseases network, 1978-1988: the transformation of tropical and global medicine
-
Adoptive transfer of heme oxygenase-1 (HO-1)-modified macrophages rescues the nuclear factor erythroid 2-related factor (Nrf2) antiinflammatory phenotype in liver ischemia/reperfusion injury
-
Reg3α Overexpression Protects Pancreatic Beta-Cells From Cytokine-Induced Damage and Improves Islet Transplant Outcome
-
Immunomodulatory and antibacterial effects of cystatin 9 against Francisella tularensis
-
Anti-CD38 antibody therapy: windows of opportunity yielded by the functional characteristics of the target molecule
-
Augmenter of liver regeneration (ALR) is a novel biomarker of hepatocellular stress/inflammation: in vitro, in vivo and in silico studies
-
Long-term safety and efficacy of human-induced pluripotent stem cell (iPS) grafts in a preclinical model of retinitis pigmentosa
-
Evidence that BRCA1- or BRCA2-associated cancers are not inevitable
-
High mobility group box protein 1 (HMGB1)-partner molecule complexes enhance cytokine production by signaling through the partner molecule receptor
-
Expanding the clinical indications for α(1)-antitrypsin therapy
-
The interaction of ApoA-I and ABCA1 triggers signal transduction pathways to mediate efflux of cellular lipids
-
Resveratrol improves cardiac contractility following trauma-hemorrhage by modulating Sirt1
Subject - wd:Q6895961